306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)

Autor: Kebriaei, P., Isola, L., Bahceci, E., Holland, H.K., Rowley, S., McGuirk, J., Devetten, M., Jansen, J., Herzig, R., Schuster, M., Uberti, J.
Zdroj: In Biology of Blood and Marrow Transplantation 2007 13(2) Supplement:111-111
Databáze: ScienceDirect
Externí odkaz: